Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding

Author(s):
Wall, S.J. van der; Lopes, R.D.; Aisenberg, J.; Reilly, P.; Ryn, J. van; Glund, S.; Elsaesser, A.; Klok, F.A.; Pollack, C.V.; Huisman, M.V. (0000-0003-1423-5348)
Published
2019
Publication type
Article / Letter to editor
atrial fibrillationdabigatrangastrointestinal hemorrhageidarucizumab
Date issued
2019-02-05
Language
English
Is part of
Circulation (2019), Vol. 139, no. 6, p. 748-756
hdl
1887/119556
doi
10.1161/CIRCULATIONAHA.118.036710